1. P.064 FIREFISH Part 1: 1-year results on motor function in infants with Type 1 spinal muscular atrophy (SMA) receiving risdiplam (RG7916). (5th June 2019) Authors: Seabrook, TJ; Baranello, G; Servais, L; Day, JW; Deconinck, N; Mercuri, E; Klein, A; Darras, B; Masson, R; Kletzl, H; Cleary, Y; El-Khairi, M; Czech, C; Gerber, M; Nguyen, C; Gelblin, K; Gorni, K; Khwaja, O; Cabalteja, C Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.064 FIREFISH Part 1: 1-year results on motor function in infants with Type 1 spinal muscular atrophy (SMA) receiving risdiplam (RG7916). (June 2019) Authors: Seabrook, TJ; Baranello, G; Servais, L; Day, JW; Deconinck, N; Mercuri, E; Klein, A; Darras, B; Masson, R; Kletzl, H; Cleary, Y; El-Khairi, M; Czech, C; Gerber, M; Nguyen, C; Gelblin, K; Gorni, K; Khwaja, O; Cabalteja, C Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.113 A Population-based Study of the Epidemiology, Healthcare Resource Utilization and Costs of Duchenne Muscular Dystrophy in Alberta, Canada. (November 2021) Authors: Chen, G; Sharif, B; Farris, MS; Cowling, T; Cabalteja, C; Wu, JJ; Maturi, B; Klein-Panneton, K; Mah, JK Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗